---
category: market-operations
circular_id: 99132d6ca3b19597
date: '2025-12-29'
description: NSE announces web-based bidding platform availability for Nectar Lifesciences
  Limited's buyback offer of up to 3 crore equity shares at Rs. 27 per share under
  the Tender Offer scheme.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CMTR72034.pdf
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Company-specific buyback offer affecting shareholders of Nectar Lifesciences
  Limited. Moderate impact limited to single stock with standard buyback procedure
  through NSE platform.
pdf_url: https://nsearchives.nseindia.com/content/circulars/CMTR72034.pdf
processing:
  attempts: 1
  content_hash: aad2af9248f55704
  processed_at: '2025-12-29T12:51:15.456817'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-29T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CMTR72034.pdf
severity: medium
source: nse
stocks:
- NECLIFE
tags:
- buyback
- tender-offer
- web-based-bidding
- capital-market
- eipo-platform
title: Buyback Offer under Tender Offer scheme by Nectar Lifesciences Limited
---

## Summary

Nectar Lifesciences Limited will conduct a buyback offer under the Tender Offer scheme using NSE's web-based bidding platform. The company will buy back up to 3,00,00,000 equity shares at Rs. 27 per share. All Capital Market segment trading members are eligible to participate in the facility.

## Key Points

- Buyback of up to 3 crore equity shares of Nectar Lifesciences Limited
- Fixed offer price: Rs. 27 per equity share
- Face value: Re. 1 per share
- Lot size: 1 equity share
- ISIN: INE023H01027
- Security symbol: NECLIFE (Series: BB)
- Merchant Banker: Master Capital Services Limited
- Registrar: KFin Technologies Limited
- Trading members can use existing IPO bidding platform credentials
- New users can access via admin terminal (Adminxxxxx format where xxxxx is Member Code)

## Regulatory Changes

No regulatory changes. This circular implements the existing Tender Offer Scheme framework as per NSE circular NSE/CMTR/52776 dated June 29, 2022.

## Compliance Requirements

- Trading members must use the web-based bidding platform at https://eipo.nseindia.com
- Members without existing access must log in to admin terminal to create branches and users
- Custodial confirmation must be completed within specified timings
- All bidding categories must follow designated status codes (FII, MF, IC, FI, OTH, CO, IND, NOH)

## Important Dates

- **Issue Period**: December 31, 2025 to January 6, 2026
- **Bidding Time**: 9:15 AM to 3:30 PM daily
- **Custodial Confirmation**: 9:15 AM to 4:00 PM (extended to 4:00 PM on issue closure date)

## Impact Assessment

This buyback offer impacts shareholders of Nectar Lifesciences Limited who wish to participate in the tender offer. The buyback provides an exit opportunity at Rs. 27 per share. Trading members need to ensure system access and user credentials are configured before the issue period begins on December 31, 2025. Eight investor categories are eligible to participate, including FIIs, mutual funds, insurance companies, banks, financial institutions, QIBs, bodies corporate, individuals, and other non-institutional investors.